Skip to content

Maternal Mindfulness: Depression and Postpartum Pain

Maternal Mindfulness to Prevent Depression and Reduce Postpartum Pain (MaMiDaPP) Intervention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05400382
Acronym
MaMiDaPP
Enrollment
75
Registered
2022-06-01
Start date
2025-12-01
Completion date
2028-03-31
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Unipolar, Pain, Postoperative

Keywords

postpartum, depression, pain, cesarean

Brief summary

This phase I clinical trial tests the feasibility and safety of a self-guided, mobile mindfulness-based intervention to reduce post-cesarean pain and prevent postpartum depression.

Detailed description

Postpartum pain affects approximately 92% of women and is a risk factor for postpartum depression (PPD). Cesarean delivery is associated with elevated risk for both postpartum pain and PPD, and women who experience persistent postpartum pain are at increased risk of developing depressive symptoms. PPD may contribute to withdrawal, emotional detachment, and hostility, which can negatively affect mother-infant interactions, including breastfeeding. These risks underscore the urgent need for an effective non-pharmacologic intervention to reduce post-cesarean delivery pain and prevent PPD. The objective of this study is to optimize a mobile, self-guided 8-week Mindfulness-Based Stress Reduction (MBSR) intervention for non-depressed women at risk for PPD who have a planned cesarean delivery. The investigators will conduct a single-group open trial of women (N = 20), including Latinas (English- and Spanish-speaking), Asian, African American, and non-Hispanic White women. The study is testing two primary hypotheses: (1) the 8-week mobile MBI will demonstrate high feasibility and acceptability among a diverse sample of women, shown by meeting target recruitment, enrollment, and retention benchmarks and (2) participants will demonstrate reductions in reported pain scores and depressive symptoms from pre- to post-intervention. In addition, the study will evaluate recruitment, enrollment, dosage, safety, and retention metrics and survey participants about intervention features, facilitators, barriers, satisfaction, and recommendations. Participants will be recruited through community partners, including the Champaign-Urbana Public Health District and the University YMCA, using flyers, partner-supported distribution of study information, and email announcements. Interested individuals will complete an online eligibility screener accessed through a QR code or URL on recruitment materials. Eligible participants will include women with an Edinburgh Postnatal Depression Scale score of 5-13 who have a planned singleton cesarean delivery, are within 18-45 years of age, and have no chronic pain condition. Individuals who meet initial eligibility criteria will be contacted by phone to confirm participant authenticity, then sent a REDCap link to complete electronic consent and a background questionnaire. After enrollment, participants will meet briefly with a trained research assistant to review access to the intervention platform and address any questions or concerns. Recruitment and enrollment will occur during the third trimester of pregnancy, and the intervention will begin during the first week following cesarean delivery.

Interventions

BEHAVIORALMindfulness

Meditation training to help reduce stress and reactivity to pain and other stressors.

Sponsors

University of Illinois at Urbana-Champaign
Lead SponsorOTHER
Southern Illinois University
CollaboratorOTHER
Arrowhead Regional Medical Center
CollaboratorOTHER
University of Utah
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

The 8-week intervention will begin in the first week post-cesarean delivery. Before the intervention begins at week 1, participants are requested to complete Numerical Pain Rating Scale (NPRS), Edinburgh Postnatal Depression Scale (EPDS), Data Collection Worksheet (DCW), Five Facet Mindfulness Questionnaire (FFMQ), Mindful Attention Awareness Scale (MAAS), Postpartum Depression Predictor (PDPI- Postpartum), Self-Acceptance Scale for Postpartum Women (SAS-PPW), Flourishing scale (FS), and Listening to Mothers California survey, Postpartum Bonding Questionnaire (PBQ) which may take approximately 20 minutes to complete (see Section 23, item 23.3 for all measures). Each intervention week, participants will engage in: A 5-10-minute self-guided mindfulness-based stress reduction (MBSR) practice through audio recordings through Canvas Free for teacher based on the submitted scripts. Based on the submitted scripts, a 5-minute self-guided audio home practice session will be provided.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. Women must self-identify as Latina/Latinx/Hispanic, Asian, African American, or non-Hispanic White. 2. Scheduled to undergo a planned cesarean delivery. 3. Be of 18-45 years of age 4. Have a singleton pregnancy 5. Score between 5 and 13 on the Edinburgh Postnatal Depression Scale (EPDS) 6. A history of depression 7. Have no chronic pain condition (e.g., fibromyalgia) 8. Own a computer, smartphone, or tablet 9. Have a reliable internet access to complete the online surveys. 10. Be proficient in English or Spanish.

Design outcomes

Primary

MeasureTime frameDescription
Post-operative pain1 week postpartum and 8 weeks postpartumNumerical Pain Rating Scale (NPRS); Participant reported pain intensity (0 is equivalent to no pain and 10 indicates the worst possible pain) and pain unpleasantness (0 is equivalent to not at all unpleasant and 10 indicates the most unpleasant feeling possible)

Secondary

MeasureTime frameDescription
Postpartum depression1 week postpartum and 8 weeks postpartumEdinburgh Postnatal Depression Scale (EPDS); participant reported depressive symptoms. Those who score above 13 are likely to be suffering from a depressive illness of varying severity.

Countries

United States

Contacts

CONTACTSandraluz Lara-Cinisomo, Ph.D.
laracini@illinois.edu217-300-3512

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026